Correlation Between Karuna Therapeutics and Propanc Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Karuna Therapeutics and Propanc Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karuna Therapeutics and Propanc Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karuna Therapeutics and Propanc Biopharma, you can compare the effects of market volatilities on Karuna Therapeutics and Propanc Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karuna Therapeutics with a short position of Propanc Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karuna Therapeutics and Propanc Biopharma.

Diversification Opportunities for Karuna Therapeutics and Propanc Biopharma

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Karuna and Propanc is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Karuna Therapeutics and Propanc Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Propanc Biopharma and Karuna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karuna Therapeutics are associated (or correlated) with Propanc Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Propanc Biopharma has no effect on the direction of Karuna Therapeutics i.e., Karuna Therapeutics and Propanc Biopharma go up and down completely randomly.

Pair Corralation between Karuna Therapeutics and Propanc Biopharma

If you would invest  0.83  in Propanc Biopharma on August 27, 2024 and sell it today you would lose (0.80) from holding Propanc Biopharma or give up 96.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy0.4%
ValuesDaily Returns

Karuna Therapeutics  vs.  Propanc Biopharma

 Performance 
       Timeline  
Karuna Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Karuna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Karuna Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Propanc Biopharma 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Propanc Biopharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain fundamental indicators, Propanc Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Karuna Therapeutics and Propanc Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Karuna Therapeutics and Propanc Biopharma

The main advantage of trading using opposite Karuna Therapeutics and Propanc Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karuna Therapeutics position performs unexpectedly, Propanc Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Propanc Biopharma will offset losses from the drop in Propanc Biopharma's long position.
The idea behind Karuna Therapeutics and Propanc Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Volatility Analysis
Get historical volatility and risk analysis based on latest market data